loader
Please Wait
Applying Filters...
menu
    • menu

    Approved Drug Products containing 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- listed with Health Canada. Original Data : Health Canada Website

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34,600Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1TARO PHARMACEUTICALS INC

    02 1ACCORD HEALTHCARE INC

    03 1BAXTER CORPORATION

    04 3PFIZER CANADA ULC

    05 1TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    TARO PHARMACEUTICALS INC

    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : TARO-DOXORUBICIN LIPOSOMAL

    Dosage Form : SUSPENSION

    Dosage Strength : 2MG/ML

    Packaging :

    Approval Date :

    Application Number : 2493020

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACCORD HEALTHCARE INC

    United Kingdom
    FNCE 2024
    Not Confirmed
    arrow

    ACCORD HEALTHCARE INC

    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : DOXORUBICIN INJECTION, BP

    Dosage Form : SOLUTION

    Dosage Strength : 2MG/ML

    Packaging : 5/25/100ML

    Approval Date :

    Application Number : 2381982

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BAXTER CORPORATION

    U.S.A
    FNCE 2024
    Not Confirmed
    arrow

    BAXTER CORPORATION

    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : CAELYX

    Dosage Form : SUSPENSION

    Dosage Strength : 2MG/ML

    Packaging :

    Approval Date :

    Application Number : 2238389

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    PFIZER CANADA ULC

    U.S.A
    FNCE 2024
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 50MG/VIAL

    Packaging : 25ML

    Approval Date :

    Application Number : 2194465

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    PFIZER CANADA ULC

    U.S.A
    FNCE 2024
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 150MG/VIAL

    Packaging : 75ML

    Approval Date :

    Application Number : 2194473

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    PFIZER CANADA ULC

    U.S.A
    FNCE 2024
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : DOXORUBICIN

    Dosage Form : SOLUTION

    Dosage Strength : 2MG/ML

    Packaging : 5/25/100ML

    Approval Date :

    Application Number : 2410397

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TEVA CANADA LIMITED

    Israel
    FNCE 2024
    Not Confirmed
    arrow

    TEVA CANADA LIMITED

    Israel
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DOXORUBICIN HYDROCHLORIDE

    Brand Name : DOXORUBICIN HYDROCHLORIDE INJECTION

    Dosage Form : SOLUTION

    Dosage Strength : 2MG/ML

    Packaging : 5/25/100ML

    Approval Date :

    Application Number : 2409275

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF